HSRx Biopharmaceutical Combination Drug Pipeline
The HSRx Combination Drug pipeline contains late-stage combination drug candidates that uniquely combine the mechanistic action of the leading generic drug treatment for the targeted disease condition with HSRx proprietary food-based single molecule and polychemical compounds which deliver multiple complementary disease-fighting mechanistic actions to create new first-in-class polyfunctional drug treatment therapies for important infectious and chronic disease conditions.
HSRx Next-Generation OTC Drug Product Portfolio
HSRx has developed a portfolio of novel FDA Monograph compliant OTC drug products. These next-generation OTC drug products will be clinically proven to outperform the category’s market leading product, enabling the rapid capture of market share. Moreover, each product is patentable and uniquely formulated with natural ingredients to appeal to today’s more health-conscious consumers.